NEUTROGENA RAPID CLEAR- salicylic acid swab 
Johnson & Johnson Consumer Inc.

Disclaimer: Most OTC drugs are not reviewed and approved by FDA, however they may be marketed if they comply with applicable regulations and policies. FDA has not evaluated whether this product complies.

----------

NEUTROGENA RAPID CLEAR

Drug Facts

Active ingredient

Salicylic Acid 2%

Purpose

Acne medication

Use

For the treatment of acne.

Warnings

For external use only.

Flammable - Keep away from fire or flame.

When using this product

  • skin irritation and dryness is more likely to occur if you use another topical acne medication at the same time. If irritation occurs, only use one topical acne medication at a time.
  • if eye contact occurs, flush thoroughly with water.

Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center right away.

Directions

Other information

Store at Room Temperature.

Sunburn Alert

This product contains an alpha hydroxy acid (AHA) that may increase your skin's sensitivity to the sun and particularly the possibility of sunburn. Use a sunscreen, wear protective clothing, and limit sun exposure while using this product and for a week afterwards.

Inactive ingredients

Water, Alcohol Denat., Butylene Glycol, PPG-5-Ceteth-20, C12-15 Alkyl Lactate, Sodium Citrate, Cocamidopropyl PG-Dimonium Chloride Phosphate, Fragrance, PEG/PPG-20/6 Dimethicone, Sodium Hydroxide, Benzalkonium Chloride, Cetyl Lactate, Disodium EDTA

Questions?

call toll-free 800-582-4048 or 215-273-8755 (collect) or visit www.neutrogena.com

Dist. by Neutrogena Corporation
Los Angeles, CA 90045

PRINCIPAL DISPLAY PANEL - 60 Pad Jar Label

NEW INFO
NEUTROGENA
Rapid Clear ®
Treatment Pads

Neutrogena ®
salicylic acid acne treatment
MICRO CLEAR™
technology

helps stop emerging
breakouts
reduces breakouts in
8 HOURS
MAXIMUM STRENGTH

60 PADS
2.12 in. (5.50cm) DIA

PRINCIPAL DISPLAY PANEL - 60 Pad Jar Label
NEUTROGENA RAPID CLEAR 
salicylic acid swab
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC:10812-204
Route of AdministrationTOPICAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
SALICYLIC ACID (UNII: O414PZ4LPZ) (SALICYLIC ACID - UNII:O414PZ4LPZ) SALICYLIC ACID20 mg
Inactive Ingredients
Ingredient NameStrength
WATER (UNII: 059QF0KO0R)  
ALCOHOL (UNII: 3K9958V90M)  
BUTYLENE GLYCOL (UNII: 3XUS85K0RA)  
PPG-5-CETETH-20 (UNII: 4AAN25P8P4)  
C12-15 ALKYL LACTATE (UNII: GC844VRD7E)  
SODIUM CITRATE, UNSPECIFIED FORM (UNII: 1Q73Q2JULR)  
COCAMIDOPROPYL PROPYLENE GLYCOL-DIMONIUM CHLORIDE PHOSPHATE (UNII: H2KVQ74JM4)  
PEG/PPG-20/6 DIMETHICONE (UNII: PWZ7N4UIKE)  
SODIUM HYDROXIDE (UNII: 55X04QC32I)  
BENZALKONIUM CHLORIDE (UNII: F5UM2KM3W7)  
CETYL LACTATE (UNII: A7EVH2RK4O)  
EDETATE DISODIUM (UNII: 7FLD91C86K)  
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:10812-204-0160 in 1 JAR; Type 0: Not a Combination Product02/09/201007/11/2024
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
OTC monograph finalpart333D02/09/201007/11/2024
Labeler - Johnson & Johnson Consumer Inc. (118772437)

Revised: 1/2023
Document Id: f306bbcf-6b94-6280-e053-2a95a90ac132
Set id: 509838e4-dbb8-4c30-9d06-f9f76bb4b07d
Version: 7
Effective Time: 20230124
 
Johnson & Johnson Consumer Inc.